Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1060855 | 0.92 | ALDH1A1 (0.36) | TSHRALDH1A1KIF11CES1 | |
| Trifluoromethanesulfonic Acid SCHEMBL6708430 | 0.82 | GPR3 (0.47) | PTPN1CA1CA2CA5ACA9 | |
| SCHEMBL12411029 | 0.81 | CYP2A6 (0.39) | ALDH1A1CES1PTPN1CA1CA2 | |
| SCHEMBL9944391 | 0.78 | PTGS1 (0.42) | ALDH1A1CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL7911698 | 0.75 | GPR3 (0.41) | TSHRALDH1A1PTPN1 | |
| SCHEMBL98413 | 0.75 | KDM4E (0.32) | ALDH1A1 | |
| SCHEMBL12411023 | 0.75 | ALDH1A1 (0.34) | TSHRALDH1A1 | |
| SCHEMBL2436976 | 0.73 | TSHR (0.43) | TSHRALDH1A1KIF11CES1PTPN1 | |
| SCHEMBL6708331 | 0.72 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL12411038 | 0.72 | ACHE (0.42) | TSHRALDH1A1CA1CA2CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059074-A1 | BICYCLIC COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | PMV PHARMACEUTICALS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4522591-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | Ventus Therapeutics U.S., Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119654326-A | Novel heterocyclic compounds | 豪夫迈·罗氏有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119212978-A | Oxoindolinyl amide derivatives for inhibiting NLRP3 and use thereof | 万特斯治疗美国公司 | 2024-12-27 | — | — | CN | disclosed |
| EP-4479403-A1 | MEMBRANE-ASSOCIATED TYROSINE-AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2024-12-25 | — | — | EP | disclosed |
| US-20240368131-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | VENTUS THERAPEUTICS U S INC (US) | 2024-11-07 | — | — | US | disclosed |
| CN-118900840-A | Membrane-associated tyrosine and threonine-specific CDC2 inhibitor kinase (PKMYT 1) inhibitors and uses thereof | 英矽智能科技知识产权有限公司 | 2024-11-05 | — | — | CN | disclosed |
| EP-4413001-A1 | PARG INHIBITORY COMPOUNDS | FoRx Therapeutics AG (CH) | 2024-08-14 | — | — | EP | disclosed |
| US-20240240066-A1 | REACTIVE ADHESIVE TAPE THAT CAN BE STAMPED | TESA SE (DE) | 2024-07-18 | — | — | US | disclosed |
| CN-117777895-A | Curable pressure sensitive adhesives with improved adhesive properties | 德莎欧洲股份公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20100035185-A1 | Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method | CENTRAL GLASS COMPANY, LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2151443-A1 | POLYHEDRAL POLYSILOXANE MODIFIED PRODUCT AND COMPOSITION USING THE MODIFIED PRODUCT | Kaneka Corporation (JP) | 2010-02-10 | — | — | EP | disclosed |
| US-7649118-B2 | Process for preparing fluorine-containing norbornene derivative | DAIKIN INDUSTRIES, LTD. (JP) | 2010-01-19 | — | — | US | disclosed |
| US-7511179-B2 | Fluorine-containing polymer, resist composition prepared from same and novel fluorine-containing monomer | DAIKIN INDUSTRIES, LTD. (JP) | 2009-03-31 | — | — | US | disclosed |
| US-20090081589-A1 | THICK FILM RESISTS | MERCK PATENT GMBH (DE) | 2009-03-26 | — | — | US | disclosed |
| US-7414148-B2 | Process for producing alkoxycarbonylfluoroalkanesulfonates | CENTRAL GLASS COMPANY LIMITED (JP) | 2008-08-19 | — | — | US | disclosed |
| US-20080108846-A1 | PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES | CENTRAL GLASS COMPANY, LIMITED (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20070129576-A1 | Process for preparing fluorine-containing norbornene derivative | DAIKIN INDUSTRIES, LTD. | 2007-06-07 | — | — | US | disclosed |
| US-7186773-B2 | Process for preparing fluorine-containing norbornene derivative | DAIKIN INDUSTRIES, LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-6215021-B1 | TRIFLUOROMETHYL DIPHENYLSULFONIUM TRIFLATE DERIVATIVES | IDAHO RESEARCH FOUNDATION, INC. | 2001-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108846-A1 | PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES | ARSA, PFAS, MPST | TSHR 3426/4885ALDH1A1 713/4885KIF11 2514/4885 |
| US-20100035185-A1 | Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method | ASIC1, RER1, INSRR | TSHR 1202/4885ALDH1A1 1210/4885KIF11 2588/4885 |
| US-20240368131-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | NLRP3, NLRP1, NOD1 | TSHR 4782/4885ALDH1A1 4026/4885KIF11 3824/4885 |
| US-20070129576-A1 | Process for preparing fluorine-containing norbornene derivative | ADH1A, FLNA, FFAR2 | TSHR 839/4885ALDH1A1 154/4885KIF11 1119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.